HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
MINT protocol
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Therapy Context: Research Results
Therapeutics: 1158551
Drug Therapy: 293145
Combination Drug Therapy: 12066
Antineoplastic Combined Chemotherapy Protocols: 35
MINT protocol: 1
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
MINT protocol: 1
Clinical Protocols
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
MINT protocol: 1
Organic Chemicals: 133
Hydrocarbons: 1713
Terpenes: 1461
Diterpenes: 1470
Taxoids: 2650
MINT protocol: 1
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Polycyclic Aromatic Hydrocarbons: 2020
Anthracenes: 12
Anthrones: 12
Anthraquinones: 788
Mitoxantrone: 2907
MINT protocol: 1
Alicyclic Hydrocarbons: 1
Cycloparaffins: 6
Cyclodecanes
Taxoids: 2650
MINT protocol: 1
Halogenated Hydrocarbons: 42
Mustard Compounds: 3
Nitrogen Mustard Compounds: 2
Phosphoramide Mustards: 5
Cyclophosphamide: 25473
Ifosfamide: 3556
MINT protocol: 1
Acyclic Hydrocarbons
Alkanes: 241
Alkanesulfonic Acids
Alkanesulfonates: 9
Mesna: 643
MINT protocol: 1
Quinones: 434
Anthraquinones: 788
Mitoxantrone: 2907
MINT protocol: 1
Organophosphorus Compounds: 300
Phosphoramides: 8
Phosphoramide Mustards: 5
Cyclophosphamide: 25473
Ifosfamide: 3556
MINT protocol: 1
Sulfur Compounds: 278
Sulfhydryl Compounds: 4168
Mesna: 643
MINT protocol: 1
Sulfur Acids
Sulfonic Acids: 1605
Alkanesulfonic Acids
Alkanesulfonates: 9
Mesna: 643
MINT protocol: 1
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Oxazines: 9
Ifosfamide: 3556
MINT protocol: 1
Polycyclic Compounds: 6
Polycyclic Aromatic Hydrocarbons: 2020
Anthracenes: 12
Anthrones: 12
Anthraquinones: 788
Mitoxantrone: 2907
MINT protocol: 1
Experts
1.
Bentley, Danielle C
: 1 article (11/2018)
2.
Thomas, Scott G
: 1 article (11/2018)
Related Diseases
1.
Herpes Zoster
11/01/2018 - "
Compared to ZONA, the MINT protocol required less time and less exercise effort, yet caused greater average BP perturbations (systolic, MINT: 16.9 ± 12.9 mm Hg, ZONA: 7.9 ± 11.6 mm Hg; diastolic, MINT: 8.7 ± 7.2 mm Hg, ZONA: 4.5 ± 4.9 mm Hg) (P < .05), with peak BP changes far below published safety guidelines.
"